ZARXIO (Sandoz Inc)
Welcome to the PulseAid listing for the ZARXIO drug offered from Sandoz Inc. This Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sandoz Inc |
| NON-PROPRIETARY NAME: | filgrastim-sndz |
| SUBSTANCE NAME: | FILGRASTIM, LICENSE HOLDER UNSPECIFIED |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC] |
| ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2015-03-06 |
| END MARKETING DATE: | 0000-00-00 |
ZARXIO HUMAN PRESCRIPTION DRUG Details:
| Item Description | ZARXIO from Sandoz Inc |
| LABELER NAME: | Sandoz Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300(ug/.5mL) |
| START MARKETING DATE: | 2015-03-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61314-304_1dde2a6f-bcf7-42d6-83ef-2069f362c3b4 |
| PRODUCT NDC: | 61314-304 |
| APPLICATION NUMBER: | BLA125553 |
Other FILGRASTIM, LICENSE HOLDER UNSPECIFIED Pharmaceutical Manufacturers / Labelers:
